GENERATION BIOTECH, LLC

Lawrenceville, NJ · Biotech · Private

CPTR, a CRISPR-based targeted capture method for long-read sequencing of large genomic DNA segments without denaturation

Grants
$611K
3 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
2
1 granted · 1 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Amplification-Free Target Enrichment and Direct Sequencing of Large Chromosomal Segments$331,252
Federal grantDepartment of Health and Human Services · Phase I · Amplification-Free Target Enrichment and Direct Sequencing of Large Chromosomal Segments$55,000
Federal grantDepartment of Health and Human Services · Phase I · Denaturation-Free DNA Target Enrichment and Direct Sequencing of Large Chromosomal Segments$224,981
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2896ANAPTYSBIO INC—$51M
2897Graywolf Therapeutics——
2898Beeline Medicines——
2899GENERATION BIOTECH, LLC——
2900ARTERY THERAPEUTICS INC——
2901FIMBRION THERAPEUTICS INC——
2902712 North Inc.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 1 granted of 2

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.